Petrus Trust Company, Lta Innoviva, Inc. Transaction History

Petrus Trust Company, Lta

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.33 - $12.48 $100,204 - $134,035	-10,740 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $125,251 - $175,691	-12,125 Reduced 53.03%	10,740 $112,000
Q2 2020 Aug 14, 2020	BUY	$11.49 - $15.26 $262,718 - $348,919	22,865 New	22,865 $320,000
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $175,896 - $230,076	-12,600 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$13.63 - $15.7 $45,892 - $52,861	-3,367 Reduced 21.09%	12,600 $192,000
Q2 2018 Aug 14, 2018	BUY	$13.44 - $17.59 $13,157 - $17,220	979 Added 6.53%	15,967 $220,000
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $87,795 - $108,090	-6,362 Reduced 29.8%	14,988 $250,000
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $250,435 - $314,912	21,350	21,350 $303,000

228

78.7M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.2B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

Stay updated on Petrus Trust Company, Lta with notifications on news.